News

Manatt Welcomes Rich Leib as National Advisor in San Diego Office

Manatt Welcomes Rich Leib as National Advisor in San Diego Office

Manatt Expands Its Horizon in San Diego with New Advisor

Manatt, Phelps & Phillips, LLP, a leader in providing integrated legal and consulting services, has made a noteworthy addition to its San Diego office. The firm proudly announces the appointment of Rich Leib as a National Advisor. This hire signifies the firm’s commitment to growth and its dedication to serving clients in a variety of industry sectors.

Rich Leib Brings a Wealth of Experience

Rich Leib arrives at Manatt with an extensive background in business, policy, education, technology, and law. He holds a distinguished position as a member of the University of California Board of Regents, recently completing a term as chair. His unique insights and expertise in navigating complex regulatory environments are a tremendous asset to the firm and its clients.

Strengthening Government Advocacy and Contracting Practices

At Manatt, Leib will contribute to the Government Advocacy and Contracting practice, enhancing the team’s ability to address intricate regulatory challenges faced by clients. "We are excited to have Rich join us; his experience in statewide policymaking will significantly bolster our capabilities in San Diego and beyond,” comments Brandon D. Young, a partner and leader of Manatt’s Government and Regulatory practice.

Growth and Expansion in San Diego

The addition of Rich Leib is part of a broader strategy of expansion for Manatt in San Diego. Since opening its office in the city, the firm has relocated to a new space at 12730 High Bluff Drive, aimed at fostering collaboration among its professionals. This move reflects the firm’s innovative approach to integrating legal and consulting services in a way that meets the evolving needs of clients.

Focus on Key Industry Sectors

Manatt's San Diego team encompasses experts from various sectors, including financial services, technology, health care, and real estate. Leib’s appointment aligns well with the firm’s objective to tap into California’s dynamic market, ensuring clients receive unparalleled support in critical areas, from regulatory guidance to strategic consulting.

Looking Ahead: A Bright Future

As Manatt continues to evolve, the firm maintains its aspiration to be at the forefront of addressing the needs of its clients across Southern California. "Rich’s deep understanding of California's corporate and government sectors will be instrumental in our growth journey," says Randy S. Grossman, a managing partner in the firm’s San Diego office.

Leib’s background includes co-founding a leading non-hazardous liquid waste recycling company and serving as general counsel for over a decade. His entrepreneurial spirit and strategic outlook perfectly fit Manatt’s mission to provide innovative solutions tailored to client needs.

Commitment to Client Success

Rich Leib expresses enthusiasm about joining Manatt, noting that his experience supporting emerging companies complements the firm’s focus on delivering exceptional results. As a firm committed to integrating legal and business insights, Leib’s role will amplify Manatt’s effectiveness in navigating the intricacies of government strategy and regulatory frameworks.

By reinforcing its distinguished team with accomplished professionals like Leib, Manatt is poised for sustained growth and can continue to support its clients in emerging opportunities and challenges. The firm’s commitment to innovation and integration remains steadfast as it champions the clients’ success across various industries.

Frequently Asked Questions

What is the significance of Rich Leib's appointment at Manatt?

Rich Leib's appointment as National Advisor enhances Manatt's capabilities in government advocacy and contracting, bringing valuable insights to clients.

How will Leib's experience benefit Manatt's clients?

Leib's extensive background in policy, education, and technology positions him to provide in-depth regulatory guidance, benefiting clients facing complex challenges.

Where is Manatt's new office located?

Manatt's San Diego office is located at 12730 High Bluff Drive, reflecting the firm’s focus on collaboration and growth.

What industries does Manatt serve?

Manatt serves various industries, including financial services, technology, health care, and real estate, ensuring tailored solutions for its diverse clientele.

What is the future outlook for Manatt in San Diego?

With its recent expansions and appointments, Manatt is well-positioned for growth, continuing to enhance its services and support clients throughout Southern California.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 17

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 311

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 35

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 68

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 147

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 0

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 113

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Preeclampsia: Key Insights for Expecting Parents

Updated Category News Views 46

Preeclampsia: Essential Insights for Expecting Parents Preeclampsia is a significant condition that often raises concerns among expecting parents. It manifests as a dangerous form of high blood pressure during pregnancy and can also surface postpartum. Understanding this condition is vital for ensuring the health and safety of both mother and child during this crucial...

Continue Reading
DTE Energy Enhances Reliability with Smart Grid Technology

Updated Category News Views 240

DTE Energy's Progress with Smart Grid Technology DTE Energy (NYSE:DTE) has announced impressive strides in enhancing energy reliability through its cutting-edge smart grid technology. This initiative has successfully prevented nearly 5,000 power interruptions and saved over 1.8 million outage minutes for customers this year, highlighting the technology's role in ensuring...

Continue Reading
Key Insider Transactions in Major US Companies Unveiled

Updated Category News Views 270

Significant Insider Trading Activities This article sheds light on the notable insider buying and selling events reported recently, reflecting the movements within major US stocks. Major Insider Purchases Berkshire Hathaway Inc. (NYSE: BRKa) has made headlines by increasing its stake in Verisign Inc. (NASDAQ: VRSN). Under the leadership of Warren E. Buffett, the company...

Continue Reading
Hull Tactical's Latest Research Paper Enhances Market Predictions

Updated Category News Views 135

Hull Tactical Releases Innovative Academic Research The Hull Tactical team is excited to unveil its latest academic paper, titled Micro Alphas, co-authored by a talented group including Blair Hull, Petra Bakosova, Francois Cocquemas, Euan Sinclair, and Petri Fast. This research introduces a fresh framework that focuses on utilizing weak yet collectively informative...

Continue Reading
Cyrano Therapeutics and KYORIN Join Forces for Smell Loss Treatment

Updated Category News Views 138

Cyrano Therapeutics and KYORIN Collaboration Overview Cyrano Therapeutics, a pioneer in regenerative medicine, has taken a significant step forward in addressing the challenge of post-viral loss of smell. The company has entered into an option agreement with KYORIN Pharmaceutical Co., Ltd. to develop CYR-064, a promising treatment candidate specifically designed for those...

Continue Reading